Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 3 news outlets
twitter: 46 X users
patent: 3 patents

facebook: 1 Facebook page
video: 1 YouTube creator

Citations

dimensions_citation: 215 Dimensions

Readers on

mendeley: 243 Mendeley

Summary News X Patents Facebook YouTube Dimensions citations

So far, Altmetric has seen 1 public wall post.

Curevac - the RNA people, 07 Jul 2015

Wir freuen uns sehr, heute die Veröffentlichung der Daten aus unserer klinischen Phase-I/IIa-Studie zur mRNA-basierten…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.